B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CGAS

MOLECULAR TARGET

cyclic GMP-AMP synthase

UniProt: Q8N884NCBI Gene: 11500415 compounds

CGAS (cyclic GMP-AMP synthase) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CGAS

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Suramin2.208
2myricetin-3-O-galactopyranoside [Supplementary Concept]1.614
3Aurintricarboxylic Acid1.614
4Idarubicin1.614
5Epirubicin1.393
6Daunorubicin1.102
7Hexachlorophene1.102
8Nisoldipine1.102
9egcg0.691
10amlexanox0.691
11Dequalinium0.691
12Disulfiram0.691
13Folic Acid0.691
14piromidic acid0.691
15Riboflavin Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables.0.691

About CGAS as a Drug Target

CGAS (cyclic GMP-AMP synthase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented CGAS interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CGAS inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.